Micropthalmia-associated Transcription Factor (MitF) is a basic helix-loop-helix leucine zipper transcription factor involved in melanocyte and osteoclast development. MiTF exists in two isoforms differing by 66 amino acids at the NH2 terminus. Melanocytes express the shorter forms of MitF with molecular weight of 52 kDa-56 kDa, while osteoclasts, mast cells and heart cells, B16 melanoma, optic cup-derived retinal pigment epithelium cells express the longer Mi form of about 60-70kDa that plays a critical role in their differentiation. MiTF Mutations leads to auditory pigmentary syndromes, such as Waardenburg Syndrome Type II, Type IIa and Tietz Syndrome in humans. This antibody identifies serine phosphorylated and non-phosphorylated melanocytic isoforms of micropthalmia. It is useful in identifying Malignant Melanoma , and distinguishing mast cell lesions of myeloid derivation. A relatively rare class of tumors known as PEComas (tumors showing perivascular epitheloid cell differentiation) express MiTF in a high percentage of cases ~90%)
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | MiTF/A13 |
| Source | Mouse |
| Tissue Type/Cancer Type | Melanoma |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
